LEADER 05376nam 22006615 450 001 9910872194703321 005 20240705125453.0 010 $a9783031594755$b(electronic bk.) 010 $z9783031594748 024 7 $a10.1007/978-3-031-59475-5 035 $a(MiAaPQ)EBC31518793 035 $a(Au-PeEL)EBL31518793 035 $a(CKB)32674597700041 035 $a(DE-He213)978-3-031-59475-5 035 $a(EXLCZ)9932674597700041 100 $a20240705d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Basics of Cancer Immunotherapy /$fedited by Haidong Dong, Svetomir N. Markovic 205 $a2nd ed. 2024. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024. 215 $a1 online resource (228 pages) 311 08$aPrint version: Dong, Haidong The Basics of Cancer Immunotherapy Cham : Springer International Publishing AG,c2024 9783031594748 320 $aIncludes bibliographical references and index. 327 $aThe basic concepts in cancer immunology and immunotherapy -- Immune checkpoint inhibitors in oncology -- Bi-specific, T cell engaging antibodies including Tebentifusp -- Cell therapy for cancer: CAR-T, TIL -- Viral immunotherapy strategies in clinical practice: TVEC -- Chemotherapy for resistant cancer to ICI -- Radio-immunotherapy for refractory cancers -- Immunotherapy for melanoma and skin cancer -- Immunotherapy for lung cancer -- Immunotherapy for breast cancer -- Immunotherapy for genitourinary malignancies -- Immunotherapy for gastrointestinal malignancies -- Immunotherapy in the solid organ transplant recipient -- Management of immune-related adverse events from immune checkpoint inhibitor therapy -- Resources for patients undergoing immune therapy for cancer -- Immunotherapy for head and neck cancer. 330 $aThis comprehensively updated new edition provides patients and their physicians (especially non-oncologist healthcare providers) with a clear and concise introduction to cancer immunotherapy. Unlike traditional forms of cancer therapy, immunotherapy acts by boosting the patient?s own immune system to fight cancer; immunotherapy's unique features make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications and maximize benefits. The patient-friendly and state-of-the-art knowledge presented in this book will inform patients and their care providers about the benefits and risks of cancer immunotherapy, and help them to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear, useful information to help them communicate with patients and address unresolved issues. Key features include: Expertise. Editors and authors are scientists and oncologists specializing in cancer immunotherapy, involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today's patient care. Their insights, expertise and experience guarantee high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written specifically for cancer patients considering or undergoing immunotherapy. As an educational tool, this book will help the reader to understand the underlying science, balance the risks and benefits based on both research and clinical facts, and make an informed decision regarding their treatment options. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors? expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, breast, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease. State-of-the-Art. This edition has been comprehensively updated to reflect recent advances, including detailed coverage of the latest therapies like CAR-T, TIL, immune checkpoint inhibitors and bispecific T cell engaging antibodies, and dedicated chapters on breast cancer, solid organ transplant recipients, GI and genitourinary malignancies, and resistant cancer. . 606 $aImmunotherapy 606 $aMedical sciences 606 $aImmunology 606 $aCancer$xTreatment 606 $aPatient education 606 $aImmunotherapy 606 $aHealth Sciences 606 $aImmunology 606 $aCancer Therapy 606 $aPatient Education 615 0$aImmunotherapy. 615 0$aMedical sciences. 615 0$aImmunology. 615 0$aCancer$xTreatment. 615 0$aPatient education. 615 14$aImmunotherapy. 615 24$aHealth Sciences. 615 24$aImmunology. 615 24$aCancer Therapy. 615 24$aPatient Education. 676 $a616.994061 702 $aDong$b Haidong 702 $aMarkovic$b Svetomir N. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910872194703321 996 $aBasics of Cancer Immunotherapy$91753997 997 $aUNINA